chrisvoncsefalvay/vaers-outcomes huggingface dataset:
G47.30 SLEEP APNEA 11/27/2022 WEAKNESS I95.9 HYPOTENSION 11/27/2022 WEAKNESS J96.00 ACUTE RESPIRATORY FAILURE 11/27/2022 WEAKNESS G47.30 SLEEP APNEA 11/27/2022 ALZHEIMERS DISEASE I95.9 HYPOTENSION 11/27/2022 ALZHEIMERS DISEASE J96.00 ACUTE RESPIRATORY FAILURE 11/27/2022 ALZHEIMERS DISEASE
A physician reported that occurrence of flu-like symptoms in a male who was vaccinated with Hep B vaccine recombinant (Engerix-B). The subject's medical history or concurrent medical conditions were not specified. On an unspecified date, the subject received the first injection of Hep B vaccine recombinant (20 mcg) intramuscularly in an unspecified arm. Concurrent medications included tetanus-diphtheria toxoid (unknown mnft'r) and a unspecified vaccine (unknown mnft'r). A few days later, he developed arthralgia, a low grade fever, and flu-like symptoms. The events were reported to have resolved within one day.
Pt. complained about being light headed after the shot - RPh noticed pt. face turn pale and pt. fainted briefly for 3-5 sec. Pt. regained consciousness and had a sweaty forehead. We monitored pt. Gave him some water and had pt. lay down. MA checked BP and O.
L thigh site red-firm-warm-mild pain Red hives around site. Diphenhydramine 12.5/5ml 12.5mgq6°prn Triamcinolone Acetonide 0.5% cream. BIdx14 days Augmentin suspension. 2.5ml Bid 50ml 0RF
Patient states arm has been sore ever since receiving vaccination 10 months ago. Has discussed with her physician but they can't think of other reason for soreness besides vaccination. I referred her back to PCP.
I started having a pain in my LUQ right under my ribs only @ night. By April I started feeling discomfort when that area was pressed. I went to the Dr. & she did a CT with contrast. She thought it was the kidney stone that showed up but turns out that had been there & would have caused back pain instead nor would it have been as intermittent. She decided to wait for further testing because it had diminished some what but now it has started bothering me again.
Chills, Slight Fever, Nausea, Exhaustion, headache and large swollen area at and surrounding the injection site.
Localized injection site redness onset 10 days s/p injection. Slightly itchy. Afebrile, non-tender. Present x2 days, unchanged, at time of visit. Advised otc antihistamines, cool compress, and continue to monitor.
Vaccination date: 14Oct2022; COVID 19 Treatment start date: 18Oct2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 67 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (non-serious) with onset Oct2022, outcome "unknown", described as "Vaccination date: 14Oct2022; COVID 19 Treatment start date: 18Oct2022". Therapeutic measures were taken as a result of covid-19.  Additional information: Patient was treated with Paxlovid from 18Oct2022 to 22Oct2022. She was not taking other medications or products within two weeks of starting COVID-19 treatment. Patient previously received a COVID-19 Vaccine. Device Date : 01Nov2022.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Patient was accidentally given FLUZONE HD.  No adverse reaction was reported at the time of conversation which occurred a few hours after receiving the vaccination.  Patient was made aware of potential Side effects that the High Dose Flu vaccine is like regular flu vaccine such as headache, soreness at the injection site, muscle aches, and fatigue
Initial information received on 25-Oct-2018 regarding an unsolicited valid non-serious case received from a physician. This case involves 15-year-old male patient who was vaccinated inadvertently with 0.5 ml expired dose of IPOL (Batch number: M1477, expiration date: 09 Sep 2018, dose, route was not reported) in left deltoid on 25 Oct 2018. The patients medical history were not reported. Concomitant medication includes ADACEL. It was an actual medication error due to expired vaccine used. It was unknown if patient had adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Sweat, injection site pain fever neauseus. 7 days couldn't work for entire week. Notified PCP.
Pt had period since she was 11 years old and had a very regular schedule monthly and last for five days. After the second shot, she started to have spotting for July's period for more than three weeks and followed by extra heavy period that last for about 10 days. Her period schedule then was messed up. She would had spotting for two weeks then followed by heavy one ever since till now
Localized erythema 4" of left thigh for 2 weeks after immunization.
NEUROPATHIC PAIN (HAVING SENSATIONS IN HEAD SUCH AS COLD, HOT, TINGLES) DUE TO WHICH UNABLE TO PERFORM NORMAL ACTIVITIES; DISCOMFORTING SENSATION IN HEAD; This spontaneous report received from a patient concerned a 40 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, treatment medications included: gabapentin. On 05-MAY-2021, the subject experienced neuropathic pain (having sensations in head such as cold, hot, tingles) due to which unable to perform normal activities. On 05-MAY-2021, the subject experienced discomforting sensation in head. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from discomforting sensation in head, and neuropathic pain (having sensations in head such as cold, hot, tingles) due to which unable to perform normal activities. This report was non-serious.
Rash on chest and lower back (1/28/19). Fever in evening and at night that got as high as 102 degrees (1/28/19). Swelling at injection site (1/28/19). Mild fever (1/29/19). Instability walking - child would lose balance or crash into objects - abnormal behavior for child (1/28/19-1/29/19). Note: Child received PCV13 starting at age 18 months (Dose 1 on 11/16/2018), (Dose 2 on 12/19/2018), (Dose 3 on 1/28/2019) -- another dose was given on (Dose 4) 3/25/2019 with adverse reactions. A separate event was filed on this site prior to this one. Note: Child received DTaP starting at age 15 months (Dose 1 on 8/16/2018), (Dose 2 on 11/20/2018 [PENTACEL]), (Dose 3 on 12/19/2018 [PENTACEL]).
She has redness and swelling at the injection site, and muscle pain. Using a cold compress and ibuprofen to help with swelling and pain.
During her 15 minute waiting period after the injection, the patient began to experience dizziness, anxiety.; During her 15 minute waiting period after the injection, the patient began to experience dizziness, anxiety.; This is a spontaneous report from a non-contactable other health professional. A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EH9899) dose number 1, intramuscularly on an unspecified date at single dose on left arm (left deltoid muscle) for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. She had no history of previous hypersensitivity reactions to immunizations. During her 15 minutes waiting period after the injection, the patient began to experience dizziness, anxiety. She denied rash, hives, difficulty breathing, difficulty swallowing, throat tightness, hoarseness, itching, facial swelling and tongue swelling. This provider was notified of patient reaction and she was then assessed in the emergency. Monitored patient for severe reaction symptoms, including rapid progression of symptoms, respiratory distress with stridor, wheezing, dyspnea and increased work of breathing, vomiting and abdominal pain. Planned action included: observation, serial examination. The action taken in response to the events for BNT162B2 was not applicable. Outcome of the events was unknown. Assessment by reporter: transient anxiety associated with COVID vaccine administration.  No follow-up attempts are possible. No further information is expected.
Mom States afternoon 5/21/07 3 pencil eraser sized red, raised areas on face and 1 on ear. Noticed 5/23 3 inch by 4 inch area on upper back/neck with pin sized, red, raised, rash
A few hours after the vaccine my left hand felt tingly. I went to sleep and woke up around 1AM with shooting pain up and down my entire left side from toes to head, my entire left side felt numb. I was unable to move my left hand temporarily. Woke up the next morning with intense bilateral pain on the back of my neck that radiated to my temporal lobes bilaterally. I had a horrible headache and felt like I could barely keep my eyes open. Took multiple naps on 8/22 as felt very exhausted. Woke up 8/23 and still had an intense bilateral headache, and felt a lack of clarity during my normal tasks. Additionally, I began to have intense vaginal pain where I typically experience my prodromal symptoms for HSV-2. This pain continues despite taking my valtrex, which typically helps the pain to subside within 24 hours. The headaches have continued and come with a continued struggle to stay alert and concentrate.  I am intermittently shakey and weak feeling.
ache; chills; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (ache), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (ache), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever). At the time of the report, PAIN (ache), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No corrective treatment was provided.   Reporter did not allow further contact
Information has been received from a licensed practical nurse referring to a 12 year old male patient. The patient had no pertinent medical history, drug reactions/allergies or concomitant medication. On 07-MAY-2016, the patient was vaccinated with a first dose of GARDASIL 9 (frequency and route were not reported). On 03-JUL-2016, the patient developed a rash from coming into contact with poison sumac. Unspecified treatment was given for the event. No lab diagnostic studies were performed. The patient's present status was reported as not recovered. The causality between the event and GARDASIL 9 was not reported. Additional information has been requested.
Woke up with high fever, extreme joint pain, incontinence, body chills, extreme exhaustion.  After finally figuring out she was given pertussis, she hadn't been told that was in the vaccine, we called the Dr. who checked her vitals and recommended rest and the use of an allergy medicine.
Patient describes weakness in the arm that he received his flu vaccine. The weakness has been occurring since about a week after getting the vaccine.
Following administration of Varivax and MMR, developed a hive at site of administration. Pt was given the above vaccines in opposing arms. And had the local red reaction in each arm. Given Benadryl po.
Red, swollen arm. Pain below injection site. Fever, diarrhea, nausea
MENACTRA dose was inadvertently used as diluent for MENVEO dose. No symptoms or adverse reaction noted.
She was dizzy 4 days later; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (She was dizzy 4 days later) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (She was dizzy 4 days later). At the time of the report, DIZZINESS (She was dizzy 4 days later) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported. The patient experienced dizzy  a very normal aftermath of the booster.
14 minutes after vaccine,  got a really bad headache for 5 minutes, then went flushed.  Felt a little swelling in the throat .  Observation in ER, no meds given.
Started with fever and progressed to red bleeding lips, then rash, swollen feet and hands, strawberry tongue
The patient left the pharmacy fine but came back a few minutes later feeling overheated and needed to set. The she started to breath shallowly and go in and out of consiousness. An ambulence was called and she was taken to the hospital
17 x 10cm area of erythema on left thigh with 8 x 6cm central area of induration. Very hot. Began about 24-30 hours after injection.
Patient is a 58 y.o. male with a history of pancreatic cancer, IDDM2, seizure disorder, recent hospital admit 11/27/22-12/1/22 for planned surgery (s/p exploratory laparotomy, partial hepatectomy, CCY and omental flap on 11/28/22) by Dr. (surgical onc.) who re-presented to hospital 12/4/2022 with congestion, dyspnea, dry cough, fevers/chills, lethargy, and hypoxia after recent diagnosis of COVID-19 on 12/3/22.    1. COVID-19: Presented as above. Symptom onset ~12/1/22, tested positive on 12/3/22, vaccinated and boosted x 1. CTPA 12/4/22 negative for PE, stable b/l pulmonary nodules, mild bibasilar atelectasis. Supportive care, symptom control, Decadron and Remdesivir initiated 12/5/22. Clinically improved.discharged on decadron till 12/13/2022. 2. Acute Hypoxic Respiratory Failure: In setting of COVID-19. SpO2 85-90% on RA at home with improvement on 2L NC. Improved to RA on 12/6/22. 3. SIRS: Met criteria with HR and RR elevated, though afebrile/WBC and lactate WNL. In setting of COVID-19 and respiratory failure. Blood cultures x 2 negative to date .  4. AKI: Baseline Cr ~1.0, admit Cr 1.48. Suspect pre-renal due to hypovolemia. Avoid nephrotoxic medications as able. Held home ACEi. Resolved. Lisinopril resumed in low dose on discharge. 5. Diarrhea: Watery and malodorous, recently given Ancef peri-op last admit. Held bowel regimen. Stool PCR 12/4 neg. Resolved. 6. Elevated Troponin: Admit troponin 43-41. No anginal symptoms on admit. EKG non-ischemic, similar to prior. Suspect due to demand/decreased renal clearance. No further workup at this time.  7. Pancreatic Adenocarcinoma: Known hx, follows with Dr. (Surgical Onc) and Dr. (Med Onc). On FOLFIRINOX as outpatient. CT C/A/P 11/17/22 with stable findings. S/p exploratory laparotomy, partial hepatectomy, CCY and omental flap on 11/28/22. Continued post-op pain control. Surgical oncology followed  8. IDDM2: Known hx, A1c 8.7% in 11/2022. Follows with Dr. (endocrinology). Home meds resumed on discharge. 9. HTN: Known hx, controlled on admit. Held home ACEi due to AKI, low dose resumed on discharge. 10. Chronic Anemia: Baseline Hgb ~11, admit Hgb 11.2, normocytic. Stable since recent surgery. No evidence of acute blood loss.  11. Seizure Disorder: Known hx, no acute issues. Continued Depakote.  12. Hypothyroidism: Known hx, continued home Synthroid.  13. BPH: Known hx, continued home Flomax.  14. Obesity with OSA: Body mass index is 35.87 kg/m². Non-compliant with CPAP, encourage use as able
Had first shot Friday the 9th at noon Starting itching and developed red spots on Saturday Monday night diarrhea and continued into Tuesday and then this went away The red spots kept coming and going until 7/21/21 Benadryl did not help much
On December 12, 2022 I began to be sniffly and the next day it got worse and had a fever for about an hour.  I was feeling pretty bad that night.  I took a rapid home test and was positive for COVID-19 on December 14, 2022.   I am still severely congested, and I feel like it has moved to my lungs.  I have a violent cough.  Last night my eyes began to become congested as well because in the night they would become crusted over.  I've been taking Ibuprofen, Tylenol, Excedrin to rotate for help with my headache and sinus pressure.    I also I started taking Molnupirazir (similar to Paxlovid) on December 19th and began to feel better.  But the following Monday I began to feel bad again.  I am still severely congested, and I feel like it has moved to my lungs.  I have a violent cough.  Last night my eyes began to become congested as well because in the night they would become crusted over.
Fever, decreased appetite, rash, shaky, vomiting in the 24 hours to 48 hours with the vaccine administration on 4/15/09
(R) thigh with 2 areas of red indurated skin, several cm in largest diameter, non-tender, walking normally.
12 hours after vaccine started having chills-could't get warm.  15 hours after vaccine developed severe vomiting for about 7 hours.
Pt. started having tachycardia immediately after vaccination and hives developed two hour after vaccination was given. Pt. took propanolol for tachycardia(already prescribed this medication by pcp) and bendryl for hives along with cold water. Pt. still experiencing hives today and just took loratadine and zaditor eye drops for crusty/itching eyes.
This spontaneous report was received from a medical assistant and refers to multiple unspecified patients of unknown age and gender. Patients concurrent conditions, medical history and concomitant medications were unknown. It was reported that doses of GARDASIL Lot # K011562, expiry date 08-APR-2017 (dose and administration route were not reported) that had been exposed a 34 degrees F for less than 30 minutes, were given to unspecified patients on unspecified dates. It was also confirmed that the vaccine had no previous excursion. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
Chest tightness, vomiting, diarrhea, body aches, dizziness, anxiety
Flushing, minor breathing issue, anxiousness occurring about 8 minutes after getting the vacciine.  Patient admitted to anxiety discorder.  Nurse and EMT assessed patient and obtained vitals.  Patient got out and walked and stated that he felt better.
Records show patient received initial/primary Janssen COVID vaccine 3/19/2021 (Lot 1808609). Records show received booster Moderna COVID vaccine at a mobile vaccine clinic on 04 Jan 2022. During telephone conversation with Dr. (Medical Director) in March 2022, patient reported that after receiving the Moderna booster, she was "super sick" for 4 days, with fever and aches. Treatment unknown. Outcome unknown.
Next day after vaccination, arm was sore at site of shot.  Fourth and fifth day after vaccination entire arm that was vaccinated ached to the bone, all over body muscle aches, extreme fatigue, red rash on cheeks of face, normal body temperature.  Took Tylenol to relieve body and arm aches.
Patient admitted to local hospital for new onset atrial fibrillation/flutter with rapid ventricular response.  Patient last known well at time of vaccination (no reported complications with 1st vaccination).  After 24 hrs, began feeling fatigued, with general malaise, and fever.  Presented to hospital ED  4 days after vaccination and found to be in new onset afib/flutter.   Required admission and introduction of diltiazem and metoprolol for rate control and started on rivaroxaban for anticoagulation
I've had a total of 3 Covid vaccines. First the J&J vaccine, followed by two Pfizer Covid vaccines as boosters. Did not have any problems with first Pfizer booster. However, I have had side effects after receiving the second Pfizer vaccine. I started out with an itchy palm on one hand about three days after vaccine. Then some hand and finger swelling. After that, I started to get rather severe hives and more hand and finger swelling. I've visited the urgent care center three times and have discussed the issue with primary care physician assistant. Antihistamines don't help with eliminating the hives and finger swelling. Only prednisone helps to relieve the symptoms. I'm now on my third course of prednisone, which will conclude within a few days.
This initial spontaneous report was received from a Nurse Practitioner (NP) via a company representative and refers to two patients of unknown age and gender. Medical history and concurrent medications were not provided. In August 2017 (reported as about two months ago), the patients were vaccinated with GARDASIL 9 (dose and route not provided.) It was unknown which dose in the series the patients received. While waiting at the office 15 minutes after receiving the vaccine, the patients passed out. It was noted that another patient also passed out and hit their head and went to the Emergency Room (see case # 1710USA007799). Two of the three injections came from the same lot # (lot # not provided). The outcome of the events were unknown. The NP did not provide causality assessment. Upon internal review, passed out was considered medically significant. This is one of two reports from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1710USA007799:
A mother reported that her son received his first doses of Prevnar, DTP (manufacturer unknown), IPOL (Aventis), and Hib (manufacturer unknown) and developed an ear infection in both ears in January 2002 at 2 months of age. He was treated with Augmentin (*amoxicillin/clavulante) and recovered. No further information was  available at the date of this report. The patient also developed an ear infection in both area following receipt of his second and third doses of Prevnar, DTP, IPOL and Hib vaccine. See MCN HQ2846617JUN2002 and MCN HQ28446817JUN2002/